The Global 3D Biological Printing Market was valued at USD 1.56 Billion in 2024 and is projected to reach USD 3.24 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 12.9% during the forecast period (2024–2030). This rapid expansion is driven by breakthroughs in regenerative medicine, surging demand for personalized healthcare solutions, and increasing adoption of bioprinting technologies in pharmaceutical research and clinical applications.
As medical science pushes boundaries in tissue engineering and organ fabrication, these pioneering companies are defining the future of 3D bioprinting. In this comprehensive analysis, we profile the Top 10 Companies in the 3D Biological Printing Industry—highlighting their technological innovations, market strategies, and groundbreaking contributions to healthcare.
Download FREE Sample Report: Global 3D Biological Printing Market – View in Detailed Research Report
🔟 1. Organovo Holdings Inc.
Headquarters: San Diego, California, USA
Key Offering: 3D bioprinted human tissues for drug testing and therapeutic applications
Organovo pioneered the first commercial 3D bioprinting platform for functional human tissues. Their exVive3D™ human liver and kidney tissues are transforming preclinical drug testing with unprecedented biological accuracy.
Innovation Highlights:
-
First FDA-recognized 3D bioprinted liver tissue model
-
Strategic partnerships with 15+ pharmaceutical giants
-
Advanced NovoGen Bioprinter Platform
9️⃣ 2. CELLINK (BICO Group)
Headquarters: Gothenburg, Sweden
Key Offering: Bioprinters, bioinks, and complete bioprinting ecosystems
CELLINK dominates the bioprinting hardware sector with 30% market share. Their BIO X6 bioprinter supports six printheads for multi-material constructs and recently incorporated AI-powered printing optimization.
Innovation Highlights:
-
World’s first universal bioink technology
-
Acquired 7 complementary biotech firms in 2022-23
8️⃣ 3. EnvisionTEC (Desktop Metal)
